BridgeBio Pharma, Inc. (BBIO)

NMS – Real Time Price. Currency in USD

83.93

+0.23 (0.27%)

Market open: Aug 12, 2026, 3:44 PM EDT

83.98

+0.28 (0.33%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

502M

222M

78M

Cost of goods sold

-24M

-8M

-7M

-8M

Gross Profit

478M

214M

70M

Operating expenses (excl. COGS)

-980M

-792M

-602M

-538M

Operating Income

-502M

-577M

-599M

-468M

Non-operating income, total

-230M

35M

-54M

-16M

Pretax income

-733M

-542M

-653M

-485M

Equity in earnings

Taxes

-435K

-1M

Non-controlling/minority interest

10M

After tax other income/expense

Net income before discontinued operations

-725M

-536M

-643M

-481M

Discontinued operations

Net income

-725M

-536M

-643M

-481M

Dilution adjustment

Preferred dividends

BridgeBio Pharma, Inc. (BBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BridgeBio Pharma, Inc. (BBIO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BridgeBio Pharma, Inc. (BBIO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BridgeBio Pharma, Inc. (BBIO)

Income Statement (Annual)

Income Statement (Annual)